Cassava Capex To Depreciation vs Ptb Ratio Analysis

SAVA Stock

USD 2.12 0.02 0.95%

Cassava Sciences financial indicator trend analysis is way more than just evaluating Cassava Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cassava Sciences is a good investment. Please check the relationship between Cassava Sciences Capex To Depreciation and its Ptb Ratio accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

Capex To Depreciation vs Ptb Ratio

Capex To Depreciation vs Ptb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cassava Sciences Capex To Depreciation account and Ptb Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Cassava Sciences' Capex To Depreciation and Ptb Ratio is -0.13. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of Cassava Sciences, assuming nothing else is changed. The correlation between historical values of Cassava Sciences' Capex To Depreciation and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Cassava Sciences are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Capex To Depreciation i.e., Cassava Sciences' Capex To Depreciation and Ptb Ratio go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most indicators from Cassava Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cassava Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.At present, Cassava Sciences' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 0.13, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.13.

	2023	2024	2025	2026 (projected)
Net Interest Income	7.8M	8.5M	9.8M	10.3M
Interest Income	7.8M	8.5M	9.8M	10.3M

Net Interest Income Interest Income

Cassava Sciences fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Current Liab	Non Currrent Assets Other	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.75	0.96	0.85	-0.99	-0.67	0.74	0.98	0.86	1.0	0.21	0.41	0.64	-0.06	0.92	0.8	0.22	0.82	1.0	0.48	0.91	0.83	-0.02	-0.27	0.88	-0.75
Total Current Liabilities	0.75		0.62	0.68	-0.7	-0.64	0.73	0.7	0.68	0.74	0.19	0.47	0.45	0.42	0.67	0.65	0.69	0.67	0.74	0.53	0.85	0.88	0.14	-0.19	0.67	-0.54
Total Stockholder Equity	0.96	0.62		0.91	-0.96	-0.71	0.8	0.98	0.92	0.95	0.17	0.35	0.73	-0.26	0.97	0.87	0.03	0.89	0.96	0.42	0.86	0.74	-0.08	-0.28	0.94	-0.8
Property Plant And Equipment Net	0.85	0.68	0.91		-0.82	-0.88	0.94	0.88	1.0	0.81	0.09	0.29	0.84	-0.28	0.97	0.96	0.03	1.0	0.83	0.4	0.86	0.72	-0.02	-0.23	0.98	-0.84
Net Debt	-0.99	-0.7	-0.96	-0.82		0.62	-0.7	-0.98	-0.83	-0.99	-0.23	-0.4	-0.61	0.08	-0.91	-0.77	-0.19	-0.78	-0.99	-0.45	-0.86	-0.8	0.05	0.28	-0.85	0.74
Retained Earnings	-0.67	-0.64	-0.71	-0.88	0.62		-0.89	-0.68	-0.87	-0.62	-0.36	-0.31	-0.65	0.23	-0.78	-0.94	-0.05	-0.89	-0.64	-0.44	-0.75	-0.66	0.29	0.48	-0.84	0.83
Accounts Payable	0.74	0.73	0.8	0.94	-0.7	-0.89		0.77	0.94	0.7	0.09	0.3	0.8	-0.24	0.88	0.93	0.09	0.95	0.72	0.41	0.85	0.71	-0.02	-0.23	0.93	-0.79
Cash	0.98	0.7	0.98	0.88	-0.98	-0.68	0.77		0.89	0.98	0.2	0.42	0.68	-0.1	0.94	0.84	0.18	0.85	0.98	0.47	0.87	0.81	-0.05	-0.29	0.91	-0.76
Non Current Assets Total	0.86	0.68	0.92	1.0	-0.83	-0.87	0.94	0.89		0.83	0.09	0.3	0.83	-0.27	0.98	0.96	0.04	0.99	0.84	0.4	0.87	0.73	-0.02	-0.23	0.98	-0.84
Cash And Short Term Investments	1.0	0.74	0.95	0.81	-0.99	-0.62	0.7	0.98	0.83		0.23	0.43	0.6	-0.02	0.9	0.77	0.25	0.78	1.0	0.49	0.88	0.83	-0.03	-0.28	0.85	-0.72
Net Receivables	0.21	0.19	0.17	0.09	-0.23	-0.36	0.09	0.2	0.09	0.23		0.46	-0.39	0.06	0.12	0.25	0.11	0.08	0.22	0.44	0.22	0.09	-0.9	-0.97	0.06	-0.18
Common Stock Total Equity	0.41	0.47	0.35	0.29	-0.4	-0.31	0.3	0.42	0.3	0.43	0.46		-0.02	0.26	0.29	0.35	0.37	0.29	0.43	0.98	0.45	0.36	-0.3	-0.47	0.32	0.01
Common Stock Shares Outstanding	0.64	0.45	0.73	0.84	-0.61	-0.65	0.8	0.68	0.83	0.6	-0.39	-0.02		-0.37	0.78	0.77	-0.12	0.84	0.62	0.1	0.63	0.63	0.36	0.24	0.86	-0.74
Non Current Liabilities Total	-0.06	0.42	-0.26	-0.28	0.08	0.23	-0.24	-0.1	-0.27	-0.02	0.06	0.26	-0.37		-0.27	-0.26	0.94	-0.28	-0.04	0.2	-0.03	0.3	0.29	0.08	-0.29	0.33
Other Current Assets	0.92	0.67	0.97	0.97	-0.91	-0.78	0.88	0.94	0.98	0.9	0.12	0.29	0.78	-0.27		0.91	0.03	0.95	0.91	0.38	0.88	0.73	-0.03	-0.24	0.96	-0.84
Other Stockholder Equity	0.8	0.65	0.87	0.96	-0.77	-0.94	0.93	0.84	0.96	0.77	0.25	0.35	0.77	-0.26	0.91		0.04	0.97	0.79	0.46	0.82	0.71	-0.2	-0.41	0.96	-0.84
Total Liab	0.22	0.69	0.03	0.03	-0.19	-0.05	0.09	0.18	0.04	0.25	0.11	0.37	-0.12	0.94	0.03	0.04		0.03	0.24	0.35	0.27	0.56	0.28	0.0	0.02	0.06
Property Plant And Equipment Gross	0.82	0.67	0.89	1.0	-0.78	-0.89	0.95	0.85	0.99	0.78	0.08	0.29	0.84	-0.28	0.95	0.97	0.03		0.8	0.41	0.85	0.71	-0.02	-0.23	0.98	-0.83
Total Current Assets	1.0	0.74	0.96	0.83	-0.99	-0.64	0.72	0.98	0.84	1.0	0.22	0.43	0.62	-0.04	0.91	0.79	0.24	0.8		0.49	0.89	0.83	-0.03	-0.28	0.86	-0.73
Common Stock	0.48	0.53	0.42	0.4	-0.45	-0.44	0.41	0.47	0.4	0.49	0.44	0.98	0.1	0.2	0.38	0.46	0.35	0.41	0.49		0.55	0.43	-0.28	-0.46	0.42	-0.09
Other Current Liab	0.91	0.85	0.86	0.86	-0.86	-0.75	0.85	0.87	0.87	0.88	0.22	0.45	0.63	-0.03	0.88	0.82	0.27	0.85	0.89	0.55		0.79	-0.04	-0.29	0.87	-0.69
Non Currrent Assets Other	0.83	0.88	0.74	0.72	-0.8	-0.66	0.71	0.81	0.73	0.83	0.09	0.36	0.63	0.3	0.73	0.71	0.56	0.71	0.83	0.43	0.79		0.2	-0.11	0.75	-0.69
Current Deferred Revenue	-0.02	0.14	-0.08	-0.02	0.05	0.29	-0.02	-0.05	-0.02	-0.03	-0.9	-0.3	0.36	0.29	-0.03	-0.2	0.28	-0.02	-0.03	-0.28	-0.04	0.2		0.94	0.0	0.12
Short Term Debt	-0.27	-0.19	-0.28	-0.23	0.28	0.48	-0.23	-0.29	-0.23	-0.28	-0.97	-0.47	0.24	0.08	-0.24	-0.41	0.0	-0.23	-0.28	-0.46	-0.29	-0.11	0.94		-0.2	0.28
Net Tangible Assets	0.88	0.67	0.94	0.98	-0.85	-0.84	0.93	0.91	0.98	0.85	0.06	0.32	0.86	-0.29	0.96	0.96	0.02	0.98	0.86	0.42	0.87	0.75	0.0	-0.2		-0.82
Retained Earnings Total Equity	-0.75	-0.54	-0.8	-0.84	0.74	0.83	-0.79	-0.76	-0.84	-0.72	-0.18	0.01	-0.74	0.33	-0.84	-0.84	0.06	-0.83	-0.73	-0.09	-0.69	-0.69	0.12	0.28	-0.82

Click cells to compare fundamentals

Cassava Sciences Account Relationship Matchups

Cassava Sciences fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	266.8M	234.8M	151.7M	157.5M	181.2M	116.7M
Total Current Liabilities	12.5M	7.1M	14.2M	11.8M	10.6M	7.4M
Total Stockholder Equity	253.9M	227.5M	137.5M	145.7M	167.6M	175.9M
Property Plant And Equipment Net	20.8M	23.0M	21.9M	21.0M	24.1M	25.3M
Net Debt	(233.2M)	(200.9M)	(121.1M)	(128.6M)	(115.7M)	(109.9M)
Retained Earnings	(207.3M)	(283.6M)	(380.8M)	(405.1M)	(364.6M)	(346.4M)
Accounts Payable	7.1M	4.0M	10.6M	7.7M	8.8M	9.2M
Cash	233.4M	201.0M	121.1M	128.6M	147.9M	155.3M
Non Current Assets Total	22.3M	23.6M	22.0M	21.0M	24.2M	25.4M
Cash And Short Term Investments	233.4M	201.0M	121.1M	128.6M	147.9M	102.5M
Common Stock Shares Outstanding	39.4M	40.2M	41.9M	46.6M	53.6M	56.3M
Liabilities And Stockholders Equity	266.8M	234.8M	151.7M	157.5M	181.2M	116.7M
Non Current Liabilities Total	333K	232K	0.0	79K	71.1K	67.5K
Other Current Assets	11.0M	10.2M	7.5M	7.0M	8.1M	8.5M
Other Stockholder Equity	461.2M	511.0M	518.2M	550.8M	633.4M	665.1M
Total Liab	12.9M	7.3M	14.2M	11.8M	10.6M	10.1M
Property Plant And Equipment Gross	20.8M	23.0M	24.1M	24.2M	27.8M	29.2M
Total Current Assets	244.5M	211.2M	129.6M	136.5M	157.0M	111.9M
Common Stock	35K	40K	42K	48K	55.2K	40.4K
Other Current Liab	5.3M	2.9M	3.6M	4.1M	4.7M	2.5M
Net Tangible Assets	22.1M	92.2M	252.8M	226.9M	261.0M	274.0M
Property Plant Equipment	47K	306K	20.8M	23.0M	26.4M	27.8M
Net Invested Capital	253.9M	227.5M	137.5M	145.7M	167.6M	124.9M
Net Working Capital	231.9M	204.2M	115.4M	124.8M	143.5M	112.7M
Capital Stock	35K	40K	42K	48K	55.2K	38.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc

When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:

How To Invest In Cassava

Details

Is Cassava Stock a good investment?

Details

What is Cassava Sciences' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.22)

Return On Assets

(0.30)

Return On Equity

(0.89)

The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Cassava Capex To Depreciation vs Ptb Ratio Analysis

Capex To Depreciation vs Ptb Ratio

Capex To Depreciation vs Ptb Ratio Correlation Analysis

Correlation Coefficient

Capex To Depreciation

Ptb Ratio

Cassava Sciences fundamental ratios Correlations

Cassava Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cassava Sciences fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Cash	- 0.98	Net Debt
Short Term Debt	- 0.97	Net Receivables
Net Debt	- 0.96	Total Stockholder Equity